Skinny Shot, Skinny Shot Plus, & Skinny Shot Max Weight Loss Injections Available Now!
If you’re feeling frustrated on your weight loss journey, you’re not alone! Even with mindful eating and regular exercise, many of us struggle to see the results we’re aiming for. But what if we told you there’s a simpler way to support your body’s natural weight-loss process and help you achieve your goals? Enter Skinny Shot weight loss injections – but that’s not all…
As one of the first clinics in the county to offer the Skinny Shot, the Artemedica team is thrilled to introduce our newest additions – Skinny Shot Plus and Skinny Shot Max! This expanded line of weight loss injectables is revolutionizing the way we approach weight management. In fact, during placebo-controlled trials, some patients lost up to 24.2% of their initial body weight1!
What are Skinny Shot Weight Loss Injections?
Skinny Shot weight loss injections at Artemedica combine a personalized weight loss treatment plan and weekly injections with professional support every step of the way. Skinny Shot weight loss injectables mimic specific hormones naturally occurring in the body to regulate appetite, control blood sugar levels, boost metabolism, and help you shed unwanted weight.
Metabolism is our body’s natural process of converting food into energy. Due to genetics and other factors beyond our control, this process looks different for everyone. That’s why there is no one-size-fits-all solution to weight loss—but our line of Skinny Shot injectables is here to change the game.
Skinny Shot Weight Loss Injections Available at Artemedica:
These three innovative weight-loss injections are truly revolutionizing the way we approach personalized weight management. Here’s a breakdown of what each of these options can do for you:
Skinny Shot
Artemedica’s Skinny Shot is an injectable imitator of an appetite hormone called glucagon-like peptide-1 (GLP-1). In other words, it helps reduce cravings and tricks your body into feeling full with less food!
This is incredibly helpful for supporting weight loss efforts, especially in combination with your personal diet and exercise plan. In fact, studies show that after 68 weeks, Skinny Shot patients can lose up to 12.4% of their initial body weight2.
Skinny Shot Plus
Skinny Shot Plus tackles everything Skinny Shot does—and more! In addition to GLP-1, this injectable also mimics another appetite hormone called glucose-dependent insulinotropic polypeptide (GIP). Initial research saw participants shed up to 18% of their initial body weight after 72 weeks3.
Skinny Shot Max
The Skinny Shot Max weight loss injectable takes it a step further, targeting three hormones! Skinny Shot Max is a gastric inhibitory polypeptide (GIP) and glucagon receptor agonist that also targets the appetite hormone, glucagon-like peptide-1 (GLP-1). In only 48 weeks, studies saw patients lose up to 24.2% of their initial body weight1!
Which Skinny Shot Weight Loss Injection is Right for Me?
Every Skinny Shot weight loss injection program is unique and will depend on your physiology, weight loss goals, and daily habits. If you are interested in finding the best weight loss injection for your needs, contact Artemedica Santa Rosa, for a free consultation. If the Skinny Shot Weight Loss Program is right for you, we can create a customized weight loss injection and treatment plan tailored to your exact needs and weight goals.
About our Injection Doctor, Victor Lacombe, M.D.
Dr. Lacombe has devoted his 28 year career to helping Sonoma County residents reach their facial plastic surgery goals. In fact, he co-authored Lasers in Aesthetic Surgery which is considered a standard must-read textbook for aspiring plastic surgeons. Dr. Lacombe is certified by both the American Board of Facial Plastic and Reconstructive Surgery as well as the American Board of Otolaryngology (Head and Neck Surgery). Many men and women in Santa Rosa, Healdsburg, and throughout Sonoma County choose Dr. Lacombe as their plastic surgeon of choice because of his experience, his skill, and his passion for helping his patients.
References
- Ania M. Jastreboff, M.D., Ph.D., Lee M. Kaplan, M.D., Ph.D., Juan P. Frías, M.D., Qiwei Wu, Ph.D., Yu Du, Ph.D., Sirel Gurbuz, M.D., Tamer Coskun, M.D., Ph.D., Axel Haupt, M.D., Ph.D., Zvonko Milicevic, M.D., and Mark L. Hartman, M.D., for the Retatrutide Phase 2 Obesity Trial Investigators. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
- US Food and Drug Administration. FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
- US Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management. https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
